Vision
To develop novel anti-inflammatory antibodies to alleviate the morbidity and mortality of chronic inflammation and fibrosis

Management Team

Martin Phillips, MD, CEO
Nick Lukacs, PhD, Co-founder, CSO
John Oates, CFO

Advisors

Frank Marcoux, PhD
Roger Ulrich, PhD
Steve Kunkel, PhD
Cory Hogaboam, PhD

 

Screen Shot 2018-10-13 at 11.01.55 PM